CDR2 Polyclonal Antibody
| Code | Size | Price |
|---|
| E-AB-11068-20uL | 20uL | £125.00 |
Quantity:
| E-AB-11068-60uL | 60uL | £172.00 |
Quantity:
| E-AB-11068-120uL | 120uL | £237.00 |
Quantity:
| E-AB-11068-200uL | 200uL | £344.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
- Human
- Mouse
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunohistochemistry (IHC)
Shipping:
Ice packs
Storage:
-20°C
Further Information
Abbreviation:
CDR2
Background:
CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Concentration:
0.4 mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:50-1:200
Immunogen:
Recombinant protein of human CDR2
Purification method:
Affinity purification
Target Synonym:
AA617262;CDR 2;CDR 62;CDR2;CDR2;CDR62;Cerebellar degeneration related protein 2 62kDa;Cerebellar degeneration related protein 2;Cerebellar degeneration related protein;Cerebellar degeneration-related protein 2;Major Yo paraneoplastic antigen;MGC116181;MGC144810;MGC144811;Paraneoplastic cerebellar degeneration associated antigen;Paraneoplastic cerebellar degeneration-associated antigen;PCD 17;PCD17;RGD1310578;Yo;Yo paraneoplastic antigen
UNIProt ID:
Q01850